Related references
Note: Only part of the references are listed.Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Effect of Soothing Gan (Liver) and Invigorating Pi (Spleen) Recipes on TLR4-p38 MAPK Pathway in Kupffer Cells of Non-alcoholic Steatohepatitis Rats
Xiang-wen Gong et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2019)
Tetramethylpyrazine ameliorates depression by inhibiting TLR4-NLRP3 inflammasome signal pathway in mice
Songnian Fu et al.
PSYCHOPHARMACOLOGY (2019)
Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways
Ping-Cuo Suolang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Past, present and future perspectives in nonalcoholic fatty liver disease
Arun J. Sanyal
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Chinese Herbal Medicine Formula Shenling Baizhu San Ameliorates High-Fat Diet-Induced NAFLD in Rats by Modulating Hepatic MicroRNA Expression Profiles
Maoxing Pan et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
Pyroptosis: An inflammatory link between NAFLD and NASH with potential therapeutic implications
Juliane I. Beier et al.
JOURNAL OF HEPATOLOGY (2018)
Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats
Yupei Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism
Yong Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
Zobair M. Younossi et al.
HEPATOLOGY (2018)
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Zobair M. Younossi et al.
HEPATOLOGY (2018)
NAFLD IN 2017 Novel insights into mechanisms of disease progression
Reenam S. Khan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Differential effects of short chain fatty acids on endothelial Nlrp3 inflammasome activation and neointima formation: Antioxidant action of butyrate
Xinxu Yuan et al.
REDOX BIOLOGY (2018)
Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice
Guo Chao Niu et al.
BMC GASTROENTEROLOGY (2018)
Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin
Yuji Ogawa et al.
SCIENTIFIC REPORTS (2018)
Crosstalk between adipokines and myokines in fat browning
A. Rodriguez et al.
ACTA PHYSIOLOGICA (2017)
Protective effects of glycyrrhizic acid against non-alcoholic fatty liver disease in mice
Xue Sun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK
Qi Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPARγ
Jin-Bong Lee et al.
JOURNAL OF ENDOCRINOLOGY (2017)
Human germline hedgehog pathway mutations predispose to fatty liver
Maria J. Guillen-Sacoto et al.
JOURNAL OF HEPATOLOGY (2017)
Antioxidant dietary approach in treatment of fatty liver: New insights and updates
Alessandra Ferramosca et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease
J. Pang et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Diet, Weight Loss, and Liver Health in Nonalcoholic Fatty Liver Disease: Pathophysiology, Evidence, and Practice
Giulio Marchesini et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The role of the gut microbiota in NAFLD
Christopher Leung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Herbal medicines and nonalcoholic fatty liver disease
Hong Yao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD
Newaz Hossain et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
Xingyong Wan et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
NAFLD: A multisystem disease
Christopher D. Byrne et al.
JOURNAL OF HEPATOLOGY (2015)
Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles
Xinlu Yuan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes
Andreas L. Birkenfeld et al.
HEPATOLOGY (2014)
NLRP3 Inflammasome Activation Results in Hepatocyte Pyroptosis, Liver Inflammation, and Fibrosis in Mice
Alexander Wree et al.
HEPATOLOGY (2014)
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Alexander Wree et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Toll-like receptor signaling pathways
Takumi Kawasaki et al.
FRONTIERS IN IMMUNOLOGY (2014)
Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: An input for novel therapies
Otilia E. Frasinariu et al.
DIGESTIVE AND LIVER DISEASE (2013)
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis
Yoon Seok Roh et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
NAFLD, NASH and liver cancer
Gregory A. Michelotti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The NLRP3 Inflammasome as a Novel Player of the Intercellular Crosstalk in Metabolic Disorders
Elisa Benetti et al.
MEDIATORS OF INFLAMMATION (2013)
Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
Nobuhiko Kayagaki et al.
SCIENCE (2013)
Bioactivity of five components of Chinese herbal formula Jiangzhi granules against hepatocellular steatosis
Hai-yan Song et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2013)
Elovl6 Promotes Nonalcoholic Steatohepatitis
Takashi Matsuzaka et al.
HEPATOLOGY (2012)
Nonalcoholic fatty liver disease (NAFLD): Is it really a serious condition?
Julia Wattacheril et al.
HEPATOLOGY (2012)
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Henao-Mejia et al.
NATURE (2012)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice
Kouichi Miura et al.
GASTROENTEROLOGY (2010)
The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases
Joao-Bruno Soares et al.
HEPATOLOGY INTERNATIONAL (2010)
Elevated endotoxin levels in non-alcoholic fatty liver disease
Alison L. Harte et al.
JOURNAL OF INFLAMMATION-LONDON (2010)
The TLR4/TRIF-Mediated Activation of NLRP3 Inflammasome Underlies Endotoxin-Induced Liver Injury in Mice
Hiroko Tsutsui et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2010)
Inflammation is associated with a decrease of lipogenic factors in omental fat in women
Odile Poulain-Godefroy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies
Robert P. Myers et al.
LIVER INTERNATIONAL (2008)
Validation of endogenous control genes in human adipose tissue:: Relevance to obesity and obesity-associated type 2 diabetes mellitus
V. Catalan et al.
HORMONE AND METABOLIC RESEARCH (2007)
Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance
Herbert Tilg et al.
GASTROENTEROLOGY (2006)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Share Paper
